has approved the Promus Element Plus everolimus-eluting chromium platinum coronary stent (Boston Scientific), a thinner-strut stent currently approved for use in Europe. The stent, according to ...

The long lengths of PROMUS Element Plus were launched earlier this year. The PROMUS Element Stent features an innovative PtCr alloy and a stent design that offers greater radial strength, exceptional ...

The PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System (Boston Scientific) was designed specifically for coronary stenting. It utilizes a proprietary platinum chromium ...

DES sales have benefited from the earlier-than-expected approval of Promus Element plus in the US (in November ... FDA approval for the Epic vascular stent, which is meant to open blocked arteries ...

The PROMUS Element Stent, utilized in the PROMUS Element Stent System and the PROMUS Element™ Plus Stent System, uses a proprietary platinum chromium alloy designed specifically for coronary ...

Boston Scientific received CE Mark approval for the PROMUS Element Stent System in 2009 and for the PROMUS Element Plus Stent System in 2011. In the U.S., the PROMUS Element Plus Stent System ...

Grines notes that European cardiology centers have also reported encountering similar problems with the Promus Element and Omega (Boston Scientific) platinum chromium coronary stents, which share ...

The FDA has cleared Boston Scientific’s Promus Element Plus chromium heart stent, according to a Wall Street Journal report. The company expects the approval will add $200 million to annualized gross ...

labeling for PROMUS Element™ and PROMUS Element™ Plus Coronary Stent Systems to include three-month Dual Anti-Platelet Therapy (DAPT). This language outlines a minimum duration of three months of DAPT ...

At the 30th Annual Congress of the European Society for Gene and Cell Therapy in Brussels this week, researchers presented both preclinical and clinical ...

The U.S. Food and Drug Administration's approval of the Promus Element Plus chromium heart stent should add about $200 million to annualized gross margin in the U.S. and Japan by around the end of ...

Boston Scientific Corp on Tuesday said U.S. regulators approved its Promus Element Plus cardiac stent, designed to be easier to deliver to the artery. The approval, which came earlier than ...